CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 14 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,587 | -55.7% | 1,775 | -34.9% | 0.00% | – |
| Q2 2023 | $3,580 | -17.3% | 2,725 | 0.0% | 0.00% | – |
| Q1 2023 | $4,330 | -79.4% | 2,725 | -57.2% | 0.00% | – |
| Q4 2022 | $21,000 | +16.7% | 6,374 | -8.8% | 0.00% | – |
| Q3 2022 | $18,000 | -37.9% | 6,987 | -9.6% | 0.00% | – |
| Q2 2022 | $29,000 | -14.7% | 7,728 | +8.2% | 0.00% | – |
| Q1 2022 | $34,000 | +9.7% | 7,144 | +62.7% | 0.00% | – |
| Q4 2021 | $31,000 | -94.9% | 4,390 | -92.0% | 0.00% | -100.0% |
| Q3 2021 | $608,000 | – | 54,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,578,174 | $74,019,000 | 0.69% |
| CVI Holdings, LLC | 93,750 | $2,692,000 | 0.19% |
| Maven Securities LTD | 126,562 | $3,634,000 | 0.16% |
| BOOTHBAY FUND MANAGEMENT, LLC | 61,761 | $1,773,000 | 0.07% |
| MEITAV INVESTMENT HOUSE LTD | 8,311 | $239,000 | 0.01% |
| Ironwood Financial, llc | 167 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 76 | $2,000 | 0.00% |
| Renaissance Technologies | 7,023 | $202,000 | 0.00% |
| UBS Group AG | 834 | $24,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |